Meet Michael Gallaway O.D., FCOVD, FAAO
Dr. Gallaway has been providing vision therapy in South Jersey since 1989.
Dr. Gallaway is board certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is a Fellow in the American Academy of Optometry (AAO). He has been in private practice in the South Jersey area since 1989, specializing in vision therapy and children’s vision disorders. He is also an Associate Professor at the Pennsylvania College of Optometry at Salus University in Philadelphia. In addition to his teaching, he is involved in research in learning related vision problems, amblyopia, vision therapy for convergence insufficiency, and concussion-related vision problems. He has published many articles in optometric journals, and has lectured extensively in the US and internationally on children’s vision and vision therapy.
A Commitment to Patients and Research
Dr. Gallaway is currently the Principal Investigator at Salus/PCO for CITT-ART, a National Eye Institute funded nationwide study assessing the impact of vision therapy for convergence insufficiency on reading and attention.
In 2015, Dr. Gallaway received the Skeffington Award for Excellence in Optometric Writing from the College of Optometrists in Vision Development in recognition of his scholarly writing and research over his career.
Dr. Gallaway was the Principal Investigator at Salus University for the Convergence Insufficiency Treatment Trial (CITT), an NIH funded randomized multicenter clinical trial that was published in 2008. This study is the largest and most comprehensive study done to date on vision therapy, and conclusively showed that office based vision therapy is the treatment of choice for convergence insufficiency. Convergence insufficiency is the most common eye muscle disorder, affecting 3-5% of children and adults.
He has published many articles in optometric journals, and has lectured extensively in the US and internationally on children’s vision and vision therapy.
Dr. Gallaway is also an Investigator both in his office and at Salus University for the Pediatric Eye Disease Investigator Group (PEDIG), a nationwide research network composed of pediatric optometrists and ophthalmologists. PEDIG studies include the Amblyopia Treatment Studies, which Dr. Gallaway has participated in since 2001.
Dr. Gallaway also participates in the InfantSee Program, which provides free vision screenings for children from birth to 12 months of age.